2-201185839-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032977.4(CASP10):c.62G>A(p.Arg21His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,613,968 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R21C) has been classified as Likely benign.
Frequency
Consequence
NM_032977.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP10 | NM_032977.4 | c.62G>A | p.Arg21His | missense_variant | 2/10 | ENST00000286186.11 | NP_116759.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASP10 | ENST00000286186.11 | c.62G>A | p.Arg21His | missense_variant | 2/10 | 1 | NM_032977.4 | ENSP00000286186 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152110Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251100Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135722
GnomAD4 exome AF: 0.000144 AC: 210AN: 1461858Hom.: 1 Cov.: 31 AF XY: 0.000133 AC XY: 97AN XY: 727234
GnomAD4 genome AF: 0.000105 AC: 16AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2022 | The c.62G>A (p.R21H) alteration is located in exon 2 (coding exon 1) of the CASP10 gene. This alteration results from a G to A substitution at nucleotide position 62, causing the arginine (R) at amino acid position 21 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Autoimmune lymphoproliferative syndrome type 2A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 21 of the CASP10 protein (p.Arg21His). This variant is present in population databases (rs140813639, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CASP10-related conditions. ClinVar contains an entry for this variant (Variation ID: 1011666). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at